Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:46.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This indicates a software update rather than substantive content changes on the study page.
    Difference
    0.0%
    Check dated 2026-03-11T14:33:15.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the long funding-status notice and Revision: v3.4.1. The update does not affect the study details or how the page is used.
    Difference
    0.3%
    Check dated 2026-02-11T02:17:31.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and NIH CC operations. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T01:17:54.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Minor UI and metadata updates were made, including a glossary toggle, updated QC labeling, capitalization adjustments for the No FEAR Act notice, and an updated site revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:14:44.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.3.3 to v3.3.4, reflecting a small metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:18:42.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.